Vascular Biogenics Ltd.

NasdaqCM:VBLT Rapporto sulle azioni

Cap. di mercato: US$12.1m

Vascular Biogenics Gestione

Gestione criteri di controllo 4/4

Vascular Biogenics Il CEO è Dror Harats, nominato in Jan2001, e ha un mandato di 22.75 anni. la retribuzione annua totale è $ 887.62K, composta da 40.3% di stipendio e 59.7% di bonus, comprese azioni e opzioni aziendali. possiede direttamente 1.47% delle azioni della società, per un valore di $ 177.68K. La durata media del mandato del team dirigenziale e del consiglio di amministrazione è rispettivamente 17.8 anni e 5.4 anni.

Informazioni chiave

Dror Harats

Amministratore delegato

US$887.6k

Compenso totale

Percentuale dello stipendio del CEO40.3%
Mandato del CEO22.8yrs
Proprietà del CEO1.5%
Durata media del management17.8yrs
Durata media del Consiglio di amministrazione5.4yrs

Aggiornamenti recenti sulla gestione

How Much Are Vascular Biogenics Ltd. (NASDAQ:VBLT) Insiders Spending On Buying Shares?

Mar 17
How Much Are Vascular Biogenics Ltd. (NASDAQ:VBLT) Insiders Spending On Buying Shares?

Recent updates

VBL Therapeutics receives non-compliance letter from Nasdaq

Sep 01

VBL Therapeutics GAAP EPS of -$0.12

Aug 15

VBL Therapeutics' late-stage trial for ovarian cancer treatment does not meet main goals

Jul 19

Here's Why We're Watching Vascular Biogenics' (NASDAQ:VBLT) Cash Burn Situation

May 18
Here's Why We're Watching Vascular Biogenics' (NASDAQ:VBLT) Cash Burn Situation

Vascular Biogenics Trial Nears Full Enrollment, Price Could Jump

Sep 03

How Much Are Vascular Biogenics Ltd. (NASDAQ:VBLT) Insiders Spending On Buying Shares?

Mar 17
How Much Are Vascular Biogenics Ltd. (NASDAQ:VBLT) Insiders Spending On Buying Shares?

How Much Of Vascular Biogenics Ltd. (NASDAQ:VBLT) Do Insiders Own?

Jan 28
How Much Of Vascular Biogenics Ltd. (NASDAQ:VBLT) Do Insiders Own?

VBL Therapeutics expands the ovarian cancer trial in Europe

Dec 29

Is Vascular Biogenics (NASDAQ:VBLT) In A Good Position To Deliver On Growth Plans?

Dec 24
Is Vascular Biogenics (NASDAQ:VBLT) In A Good Position To Deliver On Growth Plans?

Vascular Biogenics Ltd. (NASDAQ:VBLT) Just Reported And Analysts Have Been Cutting Their Estimates

Nov 19
Vascular Biogenics Ltd. (NASDAQ:VBLT) Just Reported And Analysts Have Been Cutting Their Estimates

VBL Therapeutics EPS beats by $0.01, misses on revenue

Nov 16

Analisi delle retribuzioni degli amministratori delegati

Come è cambiata la remunerazione di Dror Harats rispetto agli utili di Vascular Biogenics?
DataCompenso totaleStipendioGuadagni aziendali
Jun 30 2023n/an/a

-US$16m

Mar 31 2023n/an/a

-US$25m

Dec 31 2022US$888kUS$357k

-US$32m

Sep 30 2022n/an/a

-US$38m

Jun 30 2022n/an/a

-US$35m

Mar 31 2022n/an/a

-US$34m

Dec 31 2021US$1mUS$349k

-US$30m

Sep 30 2021n/an/a

-US$28m

Jun 30 2021n/an/a

-US$27m

Mar 31 2021n/an/a

-US$25m

Dec 31 2020n/an/a

-US$24m

Sep 30 2020n/an/a

-US$23m

Jun 30 2020n/an/a

-US$22m

Mar 31 2020n/an/a

-US$21m

Dec 31 2019US$889kUS$405k

-US$19m

Sep 30 2019n/an/a

-US$18m

Jun 30 2019n/an/a

-US$18m

Mar 31 2019n/an/a

-US$17m

Dec 31 2018US$815kUS$375k

-US$20m

Sep 30 2018n/an/a

-US$10m

Jun 30 2018n/an/a

-US$11m

Mar 31 2018n/an/a

-US$12m

Dec 31 2017n/an/a

-US$10m

Sep 30 2017n/an/a

-US$21m

Jun 30 2017n/an/a

-US$18m

Mar 31 2017n/an/a

-US$16m

Dec 31 2016US$515kUS$406k

-US$16m

Compensazione vs Mercato: La retribuzione totale di Dror ($USD 887.62K ) è circa la media per le aziende di dimensioni simili nel mercato US ($USD 647.72K ).

Compensazione vs guadagni: La retribuzione di Dror è stata coerente con le performance aziendali dell'ultimo anno.

AMMINISTRATORE DELEGATO

Dror Harats (66 yo)

22.8yrs

Mandato

US$887,624

Compensazione

Prof. Dror Harats, MD, has been the Chief Executive Officer of Vascular Biogenics Ltd., since January 2001. Prof. Harats founded VBL in 2000 based on many years of research in Atherosclerosis, Vascular Bio...

Gruppo dirigente

NomePosizioneMandatoCompensazioneProprietà
Dror Harats
CEO & Director22.8yrsUS$887.62k1.47%
$ 177.7k
Samuel Backenroth
Chief Financial Officer2yrsUS$669.08k0.68%
$ 81.9k
Eyal Breitbart
Senior Vice President of Research & Operations17.8yrsUS$433.79kNessun dato
Ayelet Horn
General Counsel23.8yrsNessun datoNessun dato
Erez Feige
Senior Vice President of Business Operations1.7yrsUS$374.71kNessun dato

17.8yrs

Durata media

52yo

Età media

Gestione esperta: Il team dirigenziale di VBLT è esperto e expertise (durata media dell'incarico 17.8 anni).

Membri del Consiglio di amministrazione

NomePosizioneMandatoCompensazioneProprietà
Dror Harats
CEO & Director22.8yrsUS$887.62k1.47%
$ 177.7k
Ruth Alon
Independent Non-Executive Director13.6yrsUS$94.25k0%
$ 0
David Hastings
Independent Non-Executive Director5.8yrsUS$101.30k0%
$ 0
Ruth Arnon
Scientific Consultant & Member of Scientific Advisory Board2.3yrsNessun datoNessun dato
Marc Kozin
Independent Non-Executive Chairman3yrsUS$205.67k0.050%
$ 6.1k
Shmuel Ben-Zvi
Independent Non-Executive Director5.1yrsUS$96.88k0.077%
$ 9.4k
Patrick Wen
Member of Scientific Advisory Boardno dataNessun datoNessun dato
Andrew Brenner
Member of Scientific Advisory Boardno dataNessun datoNessun dato
Richard Penson
Member of Scientific Advisory Boardno dataNessun datoNessun dato
Timothy Cloughesy
Member of Scientific Advisory Boardno dataNessun datoNessun dato
Nicholas Butowski
Member of Scientific Advisory Boardno dataNessun datoNessun dato
Kathleen Moore
Member of Scientific Advisory Boardno dataNessun datoNessun dato

5.4yrs

Durata media

64.5yo

Età media

Consiglio di amministrazione esperto: I membri del consiglio di amministrazione di VBLT sono considerati esperti (durata media dell'incarico 5.4 anni).